PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR SECOND QUARTER ENDED September 30, 2022
03 nov. 2022 15h50 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Nov. 03, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical...
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR FIRST QUARTER ENDED JUNE 30, 2022
08 août 2022 08h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Aug. 08, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical...
PETVIVO HOLDINGS, INC. ANNOUNCES PARTICIPATION AT THE H.C. Wainwright Global Investment Conference May 23-26, 2022
17 mai 2022 07h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, May 17, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo"), an emerging biomedical device company focused on the commercialization of innovative...
PETVIVO HOLDINGS, INC. ANOUNCES LAUNCH OF NEW COMPANY AND PRODUCT WEBSITES
07 mars 2022 07h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, March 07, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative...
Mark Middleton Joins PetVivo Holdings, Inc. as the National Director of Sales
02 sept. 2021 08h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Sept. 02, 2021 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV) (the "Company") an emerging biomedical device company focused on the commercialization of innovative...
PetVivo Changes Brand Name of Signature Osteoarthritis Product to “SPRYNG”
23 août 2021 08h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Aug. 23, 2021 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV) (the "Company") an emerging biomedical device company focused on the commercialization of innovative...